Edition:
India

Medicines Co (MDCO.OQ)

MDCO.OQ on NASDAQ Stock Exchange Global Select Market

39.94USD
20 Jul 2018
Change (% chg)

$-0.14 (-0.35%)
Prev Close
$40.08
Open
$39.95
Day's High
$40.15
Day's Low
$39.89
Volume
23,766
Avg. Vol
301,040
52-wk High
$43.68
52-wk Low
$24.45

Select another date:

Tue, May 1 2018

BRIEF-Medicines Co Says CEO Clive A. Meanwell's 2017 Total Compensation Was $7.6 Million

* MEDICINES CO SAYS CEO CLIVE A. MEANWELL'S 2017 TOTAL COMPENSATION WAS $7.6 MILLION VERSUS $6.7 MILLION IN 2016 – SEC FILING Source : https://bit.ly/2KsU3bs Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-The Medicines Co Reports Q1 GAAP Loss Per Share $1.14 From Continuing Operations

* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.76 FROM CONTINUING OPERATIONS

BRIEF-The Medicines Company Announces Chief Financial Officer Transition

* THE MEDICINES COMPANY ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION

BRIEF-Medicines Co Says Board Appointed Christopher Visioli As CFO

* MEDICINES - ON MARCH 21, BOARD APPOINTED CHRISTOPHER VISIOLI CFO AND TREASURER OF COMPANY, EFFECTIVE IMMEDIATELY

Medicines Company cuts board size, activist Denner to get more control

March 1 Medicines Company on Thursday said it was cutting the number of directors on its board, a move that could give billionaire investor Alex Denner greater control.

BRIEF-The Medicines Company Appoints Sarah Schlesinger To Its Board Of Directors

* THE MEDICINES COMPANY APPOINTS SARAH SCHLESINGER TO ITS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

BRIEF-The Medicines Q4 GAAP Loss Per Share $2.19 From Continuing Operations

* THE MEDICINES COMPANY REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 BUSINESS AND FINANCIAL RESULTS

BRIEF-The Medicines Company Reaches Enrollment Target For Orion-9 Ahead Of Schedule

* THE MEDICINES COMPANY REACHES ENROLLMENT TARGET FOR ORION-9 AHEAD OF SCHEDULE Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Select another date: